Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-cardiac-congenital-malformations-following-0 Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Descriptive Analysis Modular Programs
Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Descriptive Analysis
Modular Programs
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-cardiac-congenital-malformations-following-armodafinil Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Modular Programs
Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis
Modular Programs
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Modular Programs
Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Modular Programs
https://www.sentinelinitiative.org/methods-data-tools/methods/representation-unstructured-data-across-common-data-models Representation of Unstructured Data Across Common Data Models Methods, Data, & Tools
Representation of Unstructured Data Across Common Data Models
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter Quarterly Newsletter Spotlight
Quarterly Newsletter
Spotlight
https://www.sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes Methods, Data, & Tools
Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Analyses
Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-mother Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations
Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-patients-descriptive Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis in TriNetX Analyses
Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis in TriNetX
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/onboarding-commercial-electronic-health-record-ehr-data-partners Onboarding of Commercial Electronic Health Record (EHR) Data Partners Methods, Data, & Tools
Onboarding of Commercial Electronic Health Record (EHR) Data Partners
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2 Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Analyses
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools
Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-innovation-and-methods-seminar-series 2023 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events
2023 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiovascular-outcomes-following-percutaneous-transluminal Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: A Descriptive Analysis Analyses
Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiovascular-outcomes-following-percutaneous Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis Analyses
Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-or-linked-infant Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses
Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-records-following Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses
Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/healthverity-being-evaluated-fda-s-sentinel-initiative HealthVerity Being Evaluated for FDA’s Sentinel Initiative Sentinel Initiative Events
HealthVerity Being Evaluated for FDA’s Sentinel Initiative
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-select-products-migraine-treatment-and Utilization of Select Products for Migraine Treatment and Prevention: A Descriptive Analysis Analyses
Utilization of Select Products for Migraine Treatment and Prevention: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/cerner-enviza-collaborates-fda-develop-innovative-ai-tools Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies Sentinel Initiative Events
Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/brand-generic-switching-patterns-among-advair-diskus-users Brand to Generic Switching Patterns Among Advair Diskus Users with Asthma or Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Analyses
Brand to Generic Switching Patterns Among Advair Diskus Users with Asthma or Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-missing-data-processes-ehr-data Characterizing Missing Data Processes in EHR Data Publications and Presentations
Characterizing Missing Data Processes in EHR Data
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz Zarxio (Filgrastim-sndz) & Signal Identification Studies
Zarxio (Filgrastim-sndz) & Signal Identification
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/r-package-perform-routine-structural-missing-data An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data Publications and Presentations
An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/mortality-following-long-acting-injectable-antipsychotics Mortality Following Long-Acting Injectable Antipsychotics Use in Patients with Dementia: An Inverse Probability of Treatment Weighting Analysis Analyses
Mortality Following Long-Acting Injectable Antipsychotics Use in Patients with Dementia: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/signal-detection-and-refinement-activities-within-fda-s-0 Signal Detection and Refinement Activities within FDA’s Sentinel System Publications and Presentations
Signal Detection and Refinement Activities within FDA’s Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-trinetx-four Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses Analyses
Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/bevacizumab-and-other-cancer-medication-use-pregnant Bevacizumab and Other Cancer Medication Use in Pregnant Patients: A Descriptive Analysis Analyses
Bevacizumab and Other Cancer Medication Use in Pregnant Patients: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/introducing-colab-evolution-us-canada-international Introducing CoLab: The Evolution of US-Canada International Collaboration on Drug Safety and Effectiveness Publications and Presentations
Introducing CoLab: The Evolution of US-Canada International Collaboration on Drug Safety and Effectiveness
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-patterns-among-pregnant-and Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System Publications and Presentations
Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-beta-blockers-among-pediatric-population-united Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022 Publications and Presentations
Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/association-between-race-and-covid-19-outcomes-united-states Association Between Race and COVID-19 Outcomes in the United States (2020-2021) Publications and Presentations
Association Between Race and COVID-19 Outcomes in the United States (2020-2021)
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network Publications and Presentations
High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/racial-and-ethnic-differences-treatment-hospitalized-and Racial and Ethnic Differences in Treatment of Hospitalized and Critical COVID-19, January 2021 - April 2022 Publications and Presentations
Racial and Ethnic Differences in Treatment of Hospitalized and Critical COVID-19, January 2021 - April 2022
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/variation-mother-infant-linkage-rates-jurisdiction-us Variation in Mother-Infant Linkage Rates by Jurisdiction in U.S. Medicaid Data Publications and Presentations
Variation in Mother-Infant Linkage Rates by Jurisdiction in U.S. Medicaid Data
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/diversifying-fda-s-sentinel-system-rigorous-quality Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population Publications and Presentations
Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/nlp-detection-mortality-information-publicly-available-data NLP Detection of Mortality Information from Publicly Available Data Using Deep Learning Modeling Publications and Presentations
NLP Detection of Mortality Information from Publicly Available Data Using Deep Learning Modeling
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-gonadotropin-releasing-hormone-agonist-products Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents Publications and Presentations
Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/hospitalized-arterial-and-venous-thrombotic-events-patients Hospitalized Arterial and Venous Thrombotic Events in Patients Diagnosed in the Ambulatory Setting with COVID-19 Compared to Influenza Publications and Presentations
Hospitalized Arterial and Venous Thrombotic Events in Patients Diagnosed in the Ambulatory Setting with COVID-19 Compared to Influenza
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic Publications and Presentations
Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/principled-approaches-handle-partially-observed-confounder Principled Approaches to Handle Partially Observed Confounder Data from Electronic Health Records: A Plasmode Simulation Study Publications and Presentations
Principled Approaches to Handle Partially Observed Confounder Data from Electronic Health Records: A Plasmode Simulation Study
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/triple-challenges-small-sample-sizes-both-exposure-and Triple Challenges – Small Sample Sizes in Both Exposure and Control Groups When Scanning Rare Maternal Outcomes in Signal Identification: A Simulation Study Publications and Presentations
Triple Challenges – Small Sample Sizes in Both Exposure and Control Groups When Scanning Rare Maternal Outcomes in Signal Identification: A Simulation Study
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/expanding-capabilities-unapproved-cannabis-derived-product Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022 Publications and Presentations
Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/exploring-use-electronic-health-records-ehr-data-active Exploring the Use of Electronic Health Records (EHR) Data for Active Safety Surveillance of Epidiolex in PCORnet, July 1, 2018 - July 1, 2022 Publications and Presentations
Exploring the Use of Electronic Health Records (EHR) Data for Active Safety Surveillance of Epidiolex in PCORnet, July 1, 2018 - July 1, 2022
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/percutaneous-transluminal-septal-myocardial-ablation-and-0 Percutaneous Transluminal Septal Myocardial Ablation and Common Procedural Complications Before and After the Approval of Ablysinol Publications and Presentations
Percutaneous Transluminal Septal Myocardial Ablation and Common Procedural Complications Before and After the Approval of Ablysinol
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/using-real-world-data-evaluate-comparative-effectiveness Using Real-World Data to Evaluate Comparative Effectiveness Cohorts of Azithromycin Relative to Roflumilast in Individuals with Uncontrolled Chronic Obstructive Pulmonary Disease Publications and Presentations
Using Real-World Data to Evaluate Comparative Effectiveness Cohorts of Azithromycin Relative to Roflumilast in Individuals with Uncontrolled Chronic Obstructive Pulmonary Disease
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format Methods, Data, & Tools
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/pharmacoepidemiology-and-drug-safety-best-paper-2022-novel Pharmacoepidemiology and Drug Safety Best Paper of 2022: Novel Methods for Pregnancy Drug Safety ‎Surveillance in the FDA Sentinel System Sentinel Initiative Events
Pharmacoepidemiology and Drug Safety Best Paper of 2022: Novel Methods for Pregnancy Drug Safety ‎Surveillance in the FDA Sentinel System
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis Analyses
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study-0 Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis Analyses
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/preliminary-analysis-drug-utilization-data-inform Preliminary Analysis of Drug Utilization Data to Inform the Development of the Pregnancy Safety Study Framework Publications and Presentations
Preliminary Analysis of Drug Utilization Data to Inform the Development of the Pregnancy Safety Study Framework
Publications and Presentations
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/optimizing-use-postapproval-pregnancy-safety-studies-two Optimizing the Use of Postapproval Pregnancy Safety Studies: A Two-Day Public Workshop Sentinel Initiative Events
Optimizing the Use of Postapproval Pregnancy Safety Studies: A Two-Day Public Workshop
Sentinel Initiative Events
https://www.sentinelinitiative.org/news-events/publications-presentations/fda-sentinel-system The FDA Sentinel System Publications and Presentations
The FDA Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/scalable-incident-detection-natural-language-processing Scalable Incident Detection via Natural Language Processing and Probabilistic Language Models Sentinel Initiative Events
Scalable Incident Detection via Natural Language Processing and Probabilistic Language Models
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/corticosteroids Corticosteroids & Outpatient Utilization Studies
Corticosteroids & Outpatient Utilization
Studies
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/choc-tapped-mental-health-expertise-national-ai-project CHOC Tapped for Mental Health Expertise on National AI Project Involving Electronic Medical Records Sentinel Initiative Events
CHOC Tapped for Mental Health Expertise on National AI Project Involving Electronic Medical Records
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies
Brexafemme (Ibrexafungerp) & Use in Pregnancy
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-patients-descriptive-0 Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis Analyses
Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/proton-pump-inhibitors Proton Pump Inhibitors & COVID-19 Hospitalization and Severe COVID-19 Studies
Proton Pump Inhibitors & COVID-19 Hospitalization and Severe COVID-19
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-use-biologics-and-biosimilars-sentinel Characterization of Use of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Characterization of Use of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/covid-19-hospitalization-and-severe-covid-19-infection-0 COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis Analyses
COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/covid-19-hospitalization-algorithm-defined-covid-19 COVID-19 Hospitalization Algorithm Defined in COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis Methods, Data, & Tools
COVID-19 Hospitalization Algorithm Defined in COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/severe-covid-19-algorithm-defined-covid-19 Severe COVID-19 Algorithm Defined in COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis Methods, Data, & Tools
Severe COVID-19 Algorithm Defined in COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-dispensing-and-coding-patterns-biologics-and Utilization, Dispensing, and Coding Patterns of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Utilization, Dispensing, and Coding Patterns of Biologics and Biosimilars in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/aimovig-erenumab-0 Aimovig (Erenumab) & Signal Identification Studies
Aimovig (Erenumab) & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/racial-and-ethnic-differences-covid-19-treatment-and Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis Analyses
Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/unexpected-issues-pharmacoepidemiology-studies-applying Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes Publications and Presentations
Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drugs-approved-risk-evaluation-and-mitigation-0 Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) that Employ Elements to Assure Safe Use (ETASU): A Descriptive Analysis Analyses
Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) that Employ Elements to Assure Safe Use (ETASU): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/ozempic-semaglutide Ozempic (Semaglutide) & Signal Identification Studies
Ozempic (Semaglutide) & Signal Identification
Studies
https://www.sentinelinitiative.org/methods-data-tools/methods/characterization-covid-19-vaccination-data-sdd-0 Characterization of COVID-19 Vaccination Data in the SDD Methods, Data, & Tools
Characterization of COVID-19 Vaccination Data in the SDD
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools
Sentinel Routine Querying System
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-15th-annual-sentinel-initiative-public-workshop 2023 15th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events
2023 15th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/provigil-modafinil-and-nuvigil-armodafinil-0 Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac and Non-Cardiac Malformations Studies
Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac and Non-Cardiac Malformations
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-cardiac-congenital-malformations-following Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Analyses
Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/non-cardiac-congenital-malformations-algorithm-defined Non-Cardiac Congenital Malformations Algorithm Defined in "Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis" Methods, Data, & Tools
Non-Cardiac Congenital Malformations Algorithm Defined in "Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/neupogen-filgrastim-remicade-infliximab-and-neulasta-pegfilgrastim Neupogen (Filgrastim), Remicade (Infliximab), and Neulasta (Pegfilgrastim) & Biosimilar Use Studies
Neupogen (Filgrastim), Remicade (Infliximab), and Neulasta (Pegfilgrastim) & Biosimilar Use
Studies
https://www.sentinelinitiative.org/methods-data-tools/methods/monitoring-safety-and-effectiveness-covid-19-therapeutics-aim-1-protocol Monitoring of Safety and Effectiveness of COVID-19 Therapeutics: Aim 1 Protocol Development Study Protocols & Surveillance Plan
Monitoring of Safety and Effectiveness of COVID-19 Therapeutics: Aim 1 Protocol Development
Study Protocols & Surveillance Plan
https://www.sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-electronic-health-record-ehr-and-claims Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests Methods, Data, & Tools
Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-national Characterization of Cannabis-Derived Product Users in the National Patient-Centered Clinical Research Network (PCORnet): A Descriptive Analysis Analyses
Characterization of Cannabis-Derived Product Users in the National Patient-Centered Clinical Research Network (PCORnet): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/sentinel-views-enhancement-expanding-standardized Sentinel Views Enhancement: Expanding Standardized Dashboards to Descriptive Level 1 Analyses Methods, Data, & Tools
Sentinel Views Enhancement: Expanding Standardized Dashboards to Descriptive Level 1 Analyses
Methods, Data, & Tools